Ginkgo Bioworks Holdings Inc (NYSE:DNA) price on Thursday, May 09,rose 2.98% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.92.
A look at the stock’s price movement, the close in the last trading session was $0.89. Turning to its 52-week performance, $2.55 and $0.74 were the 52-week high and 52-week low respectively. Overall, DNA moved -17.86% over the past month.
Ginkgo Bioworks Holdings Inc’s market cap currently stands at around $1.92 billion.
Turning to the stock’s technical picture we see that short term indicators suggest on average that DNA is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
DNA’s current price about 1.46% and -13.17% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 47.15, while 7-day volatility ratio is 9.09% and 11.70% in the 30-day chart. Further, Ginkgo Bioworks Holdings Inc (DNA) has a beta value of 1.43, and an average true range (ATR) of 0.10.
If we refocus on Ginkgo Bioworks Holdings Inc (NYSE:DNA), historical trading data shows that trading volumes averaged 31.60 million over the past 3 months. The company’s latest data on shares outstanding shows there are 1.53 billion shares.
The 33.30% of Ginkgo Bioworks Holdings Inc’s shares are in the hands of company insiders while institutional holders own 56.37% of the company’s shares. Current price change has pushed the stock -45.56% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the DNA stock continues to rise going into the next quarter.
